Efficacy and safety of LentiGlobin gene therapy in patients...

Cytotherapy 2019 / 05 Vol. 21; Iss. 5

Efficacy and safety of LentiGlobin gene therapy in patients with transfusion-dependent β-thalassemia and non-β0/β0 genotypes: Updated results from the completed phase 1/2 Northstar and ongoing phase 3 Northstar-2 studies

Rasko, J., Walters, M., Kwiatkowski, J., Hongeng, S., Porter, J., Sauer, M., Thrasher, A., Thuret, I., Schiller, G., Elliot, H., Deary, B., Chen, Y., Tao, G., Asmal, M., Locatelli, F., Thompson, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2019.03.578
Date:
May, 2019
File:
PDF, 60 KB
english, 2019
Conversion to is in progress
Conversion to is failed